Bausch & Lomb (TSX:BLCO) EBIT per Share : C$0.45 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb EBIT per Share?

Bausch & Lomb's EBIT per Share for the three months ended in Dec. 2023 was C$0.16. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.45.

During the past 12 months, the average EBIT per Share Growth Rate of Bausch & Lomb was -8.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was -10.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was -15.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bausch & Lomb's EBIT per Share or its related term are showing as below:

TSX:BLCO' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -21.2 Med: -10.5 Max: -8.3
Current: -10.5

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Bausch & Lomb was -8.30% per year. The lowest was -21.20% per year. And the median was -10.50% per year.

TSX:BLCO's 3-Year EBIT Growth Rate is ranked worse than
71.51% of 723 companies
in the Medical Devices & Instruments industry
Industry Median: 6.7 vs TSX:BLCO: -10.50

Bausch & Lomb's EBIT for the three months ended in Dec. 2023 was C$56 Mil.

Bausch & Lomb EBIT per Share Historical Data

The historical data trend for Bausch & Lomb's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb EBIT per Share Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

1.74

1.06

1.16

0.85

0.45

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial											0.17	-0.02	0.15	0.16	0.16

Bausch & Lomb EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bausch & Lomb's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	156.967	/	350.500
=	0.45

Bausch & Lomb's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	56.347	/	350.800
=	0.16

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.45

Bausch & Lomb (TSX:BLCO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bausch & Lomb EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.